Inside informationEnglish
Press Release: Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 27/02/2026, 13:03
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 117230_20260227